Nurse Practitioner, Adult Health · Rancho Mirage, CA
NPI
1174989875
Since 2016
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
35400 Bob Hope Dr Ste 210
Rancho Mirage, CA, 92270
Phone (760) 202-0686
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$653K
4,183 prescriptions
Company payments, 2025
$1,068
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Sin Wee Koh-Gale prescribed most often to Medicare patients was Atorvastatin Calcium, with 328 prescriptions and refills. In total Sin Wee Koh-Gale wrote 4,183 Medicare prescriptions that cost $653K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-30.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 328 | 859 | 99 | $4,110 |
| Levothyroxine Sodium Generic | 221 | 395 | 36 | $1,971 |
| Amlodipine Besylate Generic | 197 | 534 | 61 | $1,375 |
| Metformin Hcl Generic | 142 | 390 | 42 | $842 |
| Metoprolol Succinate Generic | 137 | 373 | 39 | $2,026 |
| Fluticasone Propionate Generic | 135 | 235 | 58 | $1,402 |
| Rosuvastatin Calcium Generic | 129 | 332 | 40 | $2,847 |
| Losartan Potassium Generic | 108 | 302 | 35 | $988 |
| Lisinopril Generic | 107 | 317 | 38 | $932 |
| Ozempic Semaglutide | 81 | 131 | 22 | $118K |
| Gabapentin Generic | 71 | 153 | 21 | $1,483 |
| Omeprazole Generic | 68 | 129 | 18 | $439 |
| Tamsulosin Hcl Generic | 65 | 146 | 18 | $1,108 |
| Hydrochlorothiazide Generic | 59 | 151 | 16 | $276 |
| Januvia Sitagliptin Phosphate | 53 | 93 | Under 11 | $51K |
Brand drugs: 850 claims; generic drugs: 3,308 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sin Wee Koh-Gale $1,068 ($1,068 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $225.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 6 | $225 |
| Amgen Inc. AMGN | 7 | $210 |
| Novo Nordisk Inc NVO | 8 | $148 |
| Kowa Pharmaceuticals America, Inc. | 3 | $136 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $102 |
| GlaxoSmithKline, LLC. GSK | 3 | $75.65 |
| Lilly USA, LLC LLY | 3 | $74.39 |
| Pfizer Inc. PFE | 2 | $52.15 |
| Exact Sciences Corporation EXAS | 1 | $24.51 |
| Viatris Specialty LLC | 1 | $20.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.